Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
The first successful painless IUD and transcervical procedures performed with the Carevix™ in Indianapolis, US enhancing Women’s Care in gynecology
Epalinges, Switzerland – March 15, 2024. We are thrilled to announce a groundbreaking achievement in the United States with the first patients benefiting from successful painless IUD placement and transcervical procedures using...
ASPIVIX Receives CE Mark Approval for Carevix™
ASPIVIX Receives CE Mark Approval for Carevix™ to Reduce Pain During IUD and Transcervical Procedures, Expanding Collaboration with Ambassadors Worldwide and Enhancing Women’s Health Without Fear of Pain. Epalinges, Switzerland – December...
Welcoming Excellence to Aspivix’s Board: Dr. Susan Nicholson and Jessica J. Federer
Epalinges, Switzerland – December 11, 2023 – Dr. Susan Nicholson & Jessica J. Federer join Aspivix's Board of Directors alongside Keren Leshem, fortifying the Company’s Leadership in Women's Health Care Innovation. At...
Aspivix CEO Mathieu Horras Discusses How Much IUD Insertion Can Hurt Less on X-Health.show
Renens, Switzerland - 3 October 2023 - Mathieu Horras, CEO of Aspivix, recently joined Alex Jani on the X-Health.show podcast to delve into pressing issues and innovations in women's healthcare concerning IUD...
Aspivix mentioned in MD+DI – “Removing the Pain from ‘Just a Little Pinch’ Gynecological Procedures”
Read the MD+DI (Medical Device and Diagnostic Industry) article here
Aspivix Featured in Forbes France Following Top 10 Placement at Inaugural MedFemTech Congress
Renens, Switzerland – 10 May 2023 – ASPIVIX SA, a leading Swiss startup in women's healthcare, is thrilled to announce its feature in Forbes France after securing a spot in the top...
